Butylphthalide for thinking problems in older adults with epilepsy
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a medicine called butylphthalide can help improve memory and thinking in older adults with focal epilepsy who already have mild cognitive issues. It aims to find a new way to support brain health in people with epilepsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 85 years old.
- You must have focal epilepsy for at least 2 years and be on a stable seizure medicine for at least 3 months with good seizure control (4 or fewer seizures per month).
- You must have mild to moderate memory or thinking problems (score of 18 to 25 on a common memory test).
- You cannot have dementia (like Alzheimer's), a past stroke with brain damage, or other serious conditions that affect thinking.
- You must be able to understand and speak basic Chinese and agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether structured memory and thinking exercises (cognitive stimulation) help older adults with bipolar disorder who have mild to moderate thinking and memory problems. You may be offered guided sessions designed to improve everyday thinking skills while checking safety and fit for the program.
This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.
This Phase 3 study tests whether butyphthalide can help thinking and memory improve after an acute ischemic stroke. It compares people who take the study medicine versus usual care, and measures cognitive (thinking) changes over follow-up.
This trial tests a medicine called butylphthalide (a brain-protecting drug) to see if it can help with memory and thinking problems that some people have after chemotherapy. It is for people who received paclitaxel or platinum chemo and are now cancer-free but still struggling with 'chemo brain' symptoms like forgetfulness.
This trial studies whether methylphenidate (a stimulant medicine) can improve thinking and memory problems related to epilepsy. You may be kept on your usual seizure medicines, and your thinking will be tested over about 16 weeks.
This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.
Hear when a new Focal Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.